Navigation Links
GenSight's Project Portfolio Management Solution Chosen by G&W Laboratories to Enhance Product Portfolio Management
Date:5/12/2016

GenSight, a leader in integrated software for new product and project portfolio management, resource management, Stage-Gate®, and project management, announced today that G&W Laboratories (“G&W”) has selected GenSight’s Software-as-a-Service solution to help it enhance its R&D processes related to the development of innovative new products.

G&W, a world leader and continuous innovator in pharmaceuticals designed to alleviate human suffering, recognized the need to implement advanced technology to enable and integrate portfolio management and project management. G&W selected GenSight’s technology to help them enhance their portfolio and project management processes to further fuel innovation and growth.

Kumar Kantheti, G&W’s Vice President of Portfolio Management said: “G&W chose GenSight because of its integrated capability across one platform, robust functionality that can be easily configured, and superior integration capabilities with the company’s existing business processes and data sources. GenSight’s enterprise solution will help G&W further enhance the efficiency of R&D, while prioritizing the most innovative and valuable initiatives and optimizing resource allocation across the portfolio.”

GenSight provides market-leading enterprise portfolio management software and support to both mid-sized and large corporations to help manage complex innovation, business, process, technology and capital investment programs. A market leader in Product and Project Portfolio Management, Corporate Portfolio Management, and Capital Portfolio Management, GenSight’s technology enables critical decision making on where to invest, which programs and projects to prioritize, and how to execute and bring those programs and projects to value most profitably. From idea to delivery GenSight’s comprehensive solution will help G&W accelerate successful product development, time-to-market, and value creation.

The latest version of its enterprise project portfolio management solution, GenSight v9.2, is highly scalable, provides a range of deployment options including Cloud, On-Premise and Hybrid, and comes fully-featured including dynamic HTML5 charts and graphics. GenSight’s rapidly growing client roster includes many Life Science companies, as well as leading brands in the Consumer, Chemical, and Energy Industries.

“The GenSight team is excited to work with G&W Labs as it has a history of continuous innovation and creating consumer and value” said Michael Menard, President and Co-Founder of GenSight. “G&W has developed an impressive, integrated portfolio and project management process, and we are exited G&W has selected GenSight’s technology to enhance its ability to prioritize and execute the right innovations to drive capital efficient profitable growth.”

About The GenSight Group

GenSight is the world’s leading Enterprise Portfolio Management solution today. It is the industry’s only complete platform for complex Portfolio Management, Resource Optimization, and Stage-Gate® Management. Our total solution integrates business process consulting, best-of-breed technology, and implementation methodology.

The Forrester Wave ™ recently highlighted GenSight as a leader for Portfolio Management and placed the company in the Leaders category. Just some of the organizations deploying the GenSight solution are Johnson and Johnson, Suncor Energy, Pfizer, Cisco, Natura, Westinghouse, Sun Chemical, GlaxoSmithKline and the US Department of Energy.

GenSight is an official participant of the United Nations Global Compact, enabling leading corporations around the globe to improve their fundamental ability to create a more sustainable future by optimizing the allocation of limited resource to generate the greatest good for the environment, shareholders and communities.

GENSIGHT: THE VALUE OF INSIGHT http://www.gensight.com

About G&W Laboratories

Since 1919, G&W Laboratories has developed, manufactured, and marketed pharmaceuticals designed to alleviate human suffering. We serve our customers by providing quality pharmaceuticals, valuable services, and timely information while remaining responsive to an ever-changing marketplace. We accomplish these objectives by building upon our unique history, while anticipating the future needs of the marketplace and responding quickly. For more information, please visit http://www.gwlabs.com/.

Read the full story at http://www.prweb.com/releases/2016/05/prweb13409874.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Beanfields Partners with University of Colorado Students on Branding Project
2. The Dream Builders Project to Donate $20,000 to Children's Hospital Los Angeles
3. Access Partner The Last Well Raises $4,800 For Liberian Water Projects Through First Baptist Dallas Easter Run
4. Access Passport Web-Based E-Forms and Electronic Patient Signatures Help Galway Clinic Advance Electronic Health Records Project
5. Westshore Agency Launches New Charity Campaign to Help Provide for Local Families Fighting Cancer through the Village Project
6. Nature Addicts, the all-natural Fruit Stick, is Officially Non-GMO Project Verified
7. Extreme Measures for Extreme Hospital Cause – HealthViZion CEO Begins Food Fast until 20 Hospital Pilot Projects Begin and Funding is Raised
8. Espoma Teams up with The Edible Schoolyard Project for National Garden Month
9. Doctible Launches Project to Promote Price Transparency in Healthcare
10. Medical Solutions Sponsors Planet Water’s Project 24 for World Water Day
11. CSUN Professor/Writer/Director Luciana Lagana Wins Awards at the 2016 Canada International Film Festival for Two Projects on Aging and Falling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2019)... ... February 19, 2019 , ... Union ... Cultivation LLC , a newly-licensed cannabis cultivation and manufacturing company based in Caliente, ... distillation, and ISO-7 product formulation, while Clover Creek is poised to become a ...
(Date:2/19/2019)... ... February 19, 2019 , ... O’Neil ... newest release of their enrollment kit solution, called ONEkit™ 2.0. This new tool ... new and existing customers. ONEkit is integrated with O’Neil’s Omni-channel system, allowing enrollment ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... center in the United States and a part of the Prelude Fertility ... the campus of Piedmont Atlanta Hospital. , The only reproductive endocrinology practice on ...
(Date:2/19/2019)... , ... February 19, 2019 , ... K.J. Kidd, a ... book “Dexascan: Beyond a Missed Opportunity”: an autobiographical work offered to encourage other women ... early detection. , Kidd shares, “On September 28th of 2013, I spent my ...
(Date:2/19/2019)... DIEGO (PRWEB) , ... February 19, 2019 , ... The ... with defendant Rady Children’s Hospital – San Diego on behalf of a class of ... urgent care locations between July 1, 2012, and June 30, 2013, in a class ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... YORK (PRWEB) , ... February 19, 2019 , ... ... find a cure for Job Syndrome by providing the scientific community with additional ... of Dr. Alain Fischer as Chief Scientific Officer of the Foundation’s Scientific Advisory ...
(Date:2/19/2019)... ... February 19, 2019 , ... Periodontist, ... disease that utilizes modern dental lasers. The Laser Assisted New Attachment Procedure (LANAP) ... diseased tissue, the leading cause of gum disease. Dr. Farahmand is certified and ...
(Date:2/19/2019)... , ... February 19, 2019 , ... ... based products for clinical research and software driven clinical data services, announced an ... The elluminate Clinical Data Hub is a cloud-based platform used by Life Sciences ...
Breaking Medicine Technology: